ACE and glioma: Likewise, the DD genotype predisposed risk of glioma by more than 3-fold i.e. 63.9 and 33.8% in glioma cases and controls, respectively (p<0.001), indicating the potential of ACE I/D polymorphism as a predictive marker in glioma.